The hematopoietic growth factor "Erythropoietin" enhances the therapeutic effect of mesenchymal stem cells in Alzheimer's disease

Pakistan Journal of Biological Sciences

Volumn 17, Issue 1, 2013, Pages 9-21

  Khairallah, M I ^a,b   Kassem, L A ^a,b,c   Yassin, N A ^a,b,c   Gamal El Din, M A ^a,b,c   Zekri, M ^b,c   Attia, M ^b,c  

^a German University in Cairo   (Egypt)

^b GERMAN UNIVERSITY IN CAIRO   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Alzheimer's disease; Amyloid plaques; Erythropoietin and brain derived neurotrophic factor; Lipopolysaccharide; Mesenchymal stem cells; Neurofibrillary tangles

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINE ACETYLTRANSFERASE; ENDOGLIN PROTEIN, MOUSE; ERYTHROPOIETIN; LIPOPOLYSACCHARIDE; ORGANIC COMPOUND; PKH 26; SIGNAL PEPTIDE;

ALZHEIMER DISEASE; ANIMAL; ARTICLE; BRAIN; COGNITION; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; LOCOMOTION; MALE; MAZE TEST; MESENCHYMAL STEM CELL TRANSPLANTATION; METABOLISM; MITOCHONDRIAL VOLUME; MOUSE; PATHOLOGY; PATHOPHYSIOLOGY; TREATMENT OUTCOME;

ALZHEIMER DISEASE; ANIMALS; BRAIN; BRAIN-DERIVED NEUROTROPHIC FACTOR; CHOLINE O-ACETYLTRANSFERASE; COGNITION; ERYTHROPOIETIN; GENE EXPRESSION REGULATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPOPOLYSACCHARIDES; LOCOMOTION; MALE; MAZE LEARNING; MESENCHYMAL STEM CELL TRANSPLANTATION; MICE; MITOCHONDRIAL SIZE; ORGANIC CHEMICALS; TREATMENT OUTCOME;

EID: 84887842859     PISSN: 10288880     EISSN: 18125735     Source Type: Journal    
DOI: 10.3923/pjbs.2014.9.21     Document Type: Article

References (52)

1. Alhadlaq, A. and JJ. Mao, 2004. Mesenchymal stem cells: Isolation and therapeutics. Stem Cell. Dev., 13: 436-448.
2. Altaian, D., 2005. Comparing Groups: Three or more Independent Groups of Observations in Practical Statistics for Medical Research. Chapman and Hall, London, UK.
3. Arai, K., N. Matsuki, Y. Ikegaya and N. Nishiyama, 2001. Deterioration of spatial learning performances in lipopolysaccharide-treated mice. Jpn. J. Pharmacol., 87: 195-201.
4. Blattner, J.R., L. He and JJ. Lemasters, 2001. Screening assays for the mitochondrial permeability transition using a fluorescence multiwell plate reader. Anal. Biochem., 295: 220-226.
5. Bossolasco, P., L. Cova, C. Calzarossa, S.G. Rimoldi and C. Borsotti et al., 2005. Neuro-glial differentiation of human bone marrow stem cells in vitro. Exp. Neurol., 193: 312-325.
6. Brines, M. and A. Cerami, 2005. Emerging biological roles for erythropoietin in the nervous system. Nat. Rev. Neurosci., 6: 484-494.
7. Corcoran, K.A., Y. Lu, R.S. Turner and S. Maren, 2002. Overexpression of liAPPswe impairs rewarded alternation and contextual fear conditioning in a transgenic mouse model of Alzheimer's disease. Learn Mem., 9: 243-252.
8. Cunha, J.M. and J. Masur, 1978. Evaluation of psychotropic drugs with a modified open field test. Pharmacology, 16: 259-267.
9. Danielyan, L., R. Schafer, A. Schulz, T. Ladewig and A. Lourhmati et al., 2009. Survival, neuron-like differentiation and functionality of mesenchymal stem cells in neurotoxic environment: The critical role of erythropoietin. Cell Death Differ., 16: 1599-1614.
10. Du, H., L. Guo, W. Zhang, M. Rydzewska and S. Yan, 2011. Cyclophilin D deficiency improves mitochondrial function and learning/memory in aging Alzheimer disease mouse model. Neurobiol. Aging, 32: 398-406.
11. El Sayed, N.S., L.A. Kassem and O.A. Heikal, 2009. Promising therapy for Alzheimer's disease targeting angiotensin converting enzyme and the cyclooxygense-2 isoform. Drug Discov. Ther., 3: 307-315.
12. Esneault, E., E. Pacary, D. Eddi, T. Freret and E. Tixier et al., 2008. Combined therapeutic strategy using erythropoietin and mesenchymal stem cells potentiates neurogenesis after transient focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab., 28: 1552-1563.
13. Fahnestock, M., D. Garzon, R.M. Holsinger and V. Michalski, 2002. Neurotrophic factors and Alzheimer's disease: Are we focusing on the wrong molecule? J. Neural Transm. Suppl., 62: 241-252.
14. Fonnum, F., 1975. A rapid radiochemical method for the determination of choline acetyltransferase. J. Neurochem., 24: 407-409.
15. Heo, PL, Y. Shin, W. Cho, Y. Choi, H. Kim and Y.K. Kwon, 2009. Memory improvement in ibotenic acid induced model rats by extracts of Scutellaria baicalensis. J. Ethnopharmacol., 122: 20-27.
16. Pfrnkova, M., N. Zilka, Z. Minichova, P. Koson and M. Novak, 2007. Neurodegeneration caused by expression of human truncated tau leads to progressive neurobehavioural impairment in transgenicrats. Brain Res., 1130: 206-213.
17. Kim, D.H., B.H. Yoon, Y.W. Kim, S. Lee and B.Y. Shin et al, 2007. The seed extract of Cassia obtusifolia ameliorates learning and memory impairments induced by scopolamine or transient cerebral hypoperfusion in mice. J. Pharmacol. Sci., 105: 82-93.
18. Kimani, S.T., N.B. Patell and P.G. Kioy, 2008. Effect of single and daily khat (Catha edulis) extract on locomotor behaviour in CBA mice. Sci. Res. Essay, 3: 187-196.
19. Kivipelto, M. and A. Solomon, 2008. Alzheimer's disease-the ways of prevention. J. Nutr. Health Aging, 12: 89S-94S.
20. Kwak, C, S.H. Lee, B.K. Kaang, 2009. Social isolation selectively increases anxiety in mice without affecting depress ion-like behavior. Korean J. Physiol. Pharmacol., 13: 357-360.
21. Lee, J.W., Y.K. Lee, D.Y. Yuk, D.Y. Choi, S.B. Ban, K.W. Oh and J.T. Hong, 2008. Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of beta-amyloid generation. J. Neuroinflammation, Vol. 5.
22. Lee, S.T., K. Chu, J.E. Park, K.H. Jung and D. Jeon et al., 2012. Erythropoietin improves memory function with reducing endothelial dysfunction and amyloid-beta burden in Alzheimer's disease models. J. Neurochem., 120: 115-124.
23. Levy, Y.S., M. Bahat-Stroomza, R. Barzilay, A. Burshtein and S. Bulvik et al, 2008. Regenerative effect of neural-induced human mesenchymal stromal cells in rat models of Parkinson's disease. Cytotherapy, 10: 340-352.
24. Lindvall, O. and Z. Kokaia, 2006. Stem cells for the treatment of neurological disorders. Nature, 441: 1094-1096.
25. Liu, Z.B., W.M. Niu, X.H. Yang, X.M. Niu and Y. Wang, 2009. Effect of Xiusanzhen on learning-memory ability and hippocampal ChAT and AChE activity in Alzheimer disease rats. Zhen Ci Yan Jiu, 34: 48-51.
26. Lledo, P.M., M. Alonso and M.S. Grubb, 2006. Adult neurogenesis and functional plasticity in neuronal circuits. Nat. Rev. Neurosci., 7: 179-193.
27. Lu, V., 2003. BDNF and activity-dependent synaptic modulation. Learn. Mem., 10: 86-98.
28. Mandillo, S., V. Tucci, S.M. Holter, H. Meziane and M.A. Banchaabouchi et al, 2008. Reliability, robustness and reproducibility in mouse behavioral phenotyping: A cross-laboratory study. Physiol. Genomics, 34: 243-255.
29. Miller, R.H., L. Bai, D.P. Lennon and A.I. Caplan, 2010. The potential of mesenchymal stem cells for neural repair. Discov. Med., 9: 236-242.
30. Miskowiak, K.W., M. Vinberg, C.J. Harmer, H. Ehrenreich and G.M. Knudsen et al, 2010. Effects of erythropoietin on depressive symptoms and neurocognitive deficits in depression and bipolar disorder. Trials, Vol. 11 10.1186/1745-6215-11-97
31. Munoz, J.R., B.R. Stoutenger, A.P. Robinson, J.L. Spees and D.J. Prockop, 2005. Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc. Natl. Acad. Sci. USA, 102: 18171-18176.
32. Nakayama, T., T. Momoki-Soga and N. Inoue, 2003. Astrocyte-derived factors instruct differentiation of embryonic stem cells into neurons. Neurosci. Res., 46: 241-249.
33. Pena, L.A., C.W. Brecher and D.R. Marshak, 1995. 13-Amyloid regulates gene expression of glial trophic substance SI 00/3. Mol. Brain Res., 34: 118-126.
34. Peng, S., D.J. Garzon, M. Marchese, W. Klein and S.D. Ginsberg et al, 2009. Decreased brain-derived neurotrophic factor depends on amyloid aggregation state in transgenic mouse models of Alzheimer's disease. J. Neurosci., 29: 9321-9329.
35. Pleckaityte, M., 2010. Alzheimers disease: A molecular mechanism, new hypotheses and therapeutic strategies. Med. (Kaunas), 46: 70-76.
36. Qaseem, A., V. Snow, J.T. Jr. Cross, M.A. Forciea and R. Hopkins et al, 2008. Current pharmacologic treatment of dementia: A clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann. Intern. Med., 148: 370-378.
37. Raina, P., P. Santaguida, A. Ismaila, C. Patterson and D. Cowan et al, 2008. Effectiveness of cholinesterase inhibitors and memantine for treating dementia: Evidence review for a clinical practice guideline. Ann. Intern. Med., 148: 379-397.
38. Rochefort, G.Y., P. Vaudin, N. Bonnet, J.C. Pages, J. Domenech, P. Charbord and V. Eder, 2005. Influence of hypoxia on the domiciliation of mesenchymal stem cells after infusion into rats: Possibilities of targeting pulmonary artery remodeling via cells therapies? Respir. Res., Vol. 6.
39. Salloway, S. and S. Correia, 2009. Alzheimer disease: Time to improve its diagnosis and treatment. Cleve. Clin. J. Med., 76: 49-58.
40. Sasaki, M., R. Abe, Y. Fujita, S. Ando, D. Inokuma and H. Shimizu, 2008. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by trans differentiation into multiple skin cell type. J. Immunol, 180: 2581-2587.
41. Schliebs, R. and T. Arendt, 2011. The cholinergic system in aging and neuronal degeneration. Behav. Brain Res., 221: 555-563.
42. Schnydrig, S., L. Korner, S. Landweer, B. Ernst, G. Walker, U. Otten and D. Kunz, 2007. Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain. Neurosci. Lett., 429: 69-73.
43. Schulte-Herbruggen, O., S. Eckart, U. Deicke, A. Kuhl and U. Otten et al., 2008. Age-dependent time course of cerebral brain-derived neurotrophic factor, nerve growth factor and neurotrophin-3 in APP23 transgenic mice. J. Neurosci. Res., 86: 2774-2783.
44. Sheng, J.G., S.H. Bora, G. Xu, D.R. Borchelt, D.L. Price and V.E. Koliatsos, 2003. Lipopolysaccharide-induced-neuroinflammation increases intracellular accumulation of amyloid precursor protein and amyloid beta peptide in APPswe transgenic mice. Neurobiol. Dis., 14: 133-145.
45. Song, H., C.F. Stevens and F.H. Gage, 2002. Astrogha induce neurogenesis from adult neural stem cells. Nature, 417: 39-44.
46. Swiergiel, A.H. and AJ. Dunn, 2007. Effects of inter leukin-1 [3 and lipopolysaccharide on behavior of mice in the elevated plus-maze and open field tests. Pharmacol. Biochem. Behav., 86: 651-659.
47. Toma, C, M.F. Pittenger, K.S. Cahill, BJ. Byrne and P.D. Kessler, 2002. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation, 105: 93-98.
48. Viviani, V., S. Bartesaghi, E. Corsini, P. Villa and P. Ghezzi et al., 2005. Erythropoietin protects primary hippocampal neurons increasing the expression of brain-derived neurotrophic factor. J. Neurochem., 93: 412-421.
49. Wang, Y., S.L. Chan, L. Miele, PJ. Yao and J. Mackes et at, 2004. Involvement of Notch signaling in hippocampal synaptic plasticity. Proc. Natl. Acad. Sci., 101: 9458-9462.
50. Wilkins, A., K. Kemp, M. Ginty, K. Hares, E. Mallam and N. Scolding, 2009. Human bone marrow-derived mesenchymal stem cells secrete brain-derived neurotrophic factor which promotes neuronal survival in vitro. Stem Cell Res., 3: 63-70.
51. Yardan, T., A.K. Erenler, A. Baydin, K. Aydin and S Cokluk, 2011. Usefulness of S100B protein in neurological disorders. J. Pak. Med. Assoc, 61: 276-281.
52. Zhu, H., Z.K. Guo, X.X. Jiang, H. Li and X.Y. Wang et al., 2010. A protocol for isolation and culture of mesenchymal stem cells from mouse compact bone. Nat. Protoc, 5: 550-560.